Select the name of the type of clinical care program you would like more information about …

Example: ‘B’ for Bladder Cancer

Cancer Treatment A-Z

Skip to content. | Skip to navigation

Personal tools

Navigation

You are here: Home / News / 2011 News / UNC Lineberger patient Morgan Throckmorton talks with WRAL about her diagnosis, clinical trials

UNC Lineberger patient Morgan Throckmorton talks with WRAL about her diagnosis, clinical trials

by maryruth.helms — last modified Sep 15, 2011 10:31 AM
UNC Lineberger patient Morgan Throckmorton was diagnosed with colon cancer in 2009 when she was 24 years old. She is now part of a UNC-led trial to test a new drug, Regorafinib.

Morgan Throckmorton

She talks about her diagnosis and treatment and why she wanted to take part in the clinical trial.

Dr. Bert O'Neil, a faculty member in UNC Lineberger's Gastrointestinal Oncology program, talks about the K-RAS mutation - which Throckmorton tested positive for - which is present in about a third of colon cancer cases.

Read more and watch videoIcon indicating that a link will open an external site..

Filed under: , , ,